Journal of Medicinal ChemistryMolecular BiologyPeer-reviewed journal article
Discovery of a first-in-class small molecule ligand for WDR91 using DNA-encoded chemical library selection followed by machine learning
Shabbir AhmadiD, Jin Bao XuiD, Jianwen A. FengiD, Ashley HutchinsoniD, Hong ZengiD, Pegah Ghiabi, Aiping DongiD, Paolo A. Centrella, Matthew ClarkiD, Marie-Aude Guié, John P. Guilinger, Anthony D. KeefeiD, Ying ZhangiD, Thomas Cerruti, John W. CuozzoiD, Moritz von Rechenberg, Albina Bolotokova, Yanjun LiiD, P. LoppnauiD, Alma Seitova, Yen-Yen LiiD, Vijayaratnam SanthakumariD, Peter J. BrowniD, Suzanne Z. AcklooiD, Levon HalabelianiD
Abstract
WD40 repeat-containing protein 91 regulates endosomal phosphatidylinositol 3-phosphate levels at the critical stage of endosome maturation and plays vital roles in endosome fusion, recycling, and transport by mediating protein-protein interactions. Due to its various roles in endocytic pathways, WDR91 has recently been identified as a potential host factor responsible for viral infection. We employed DNA-Encoded Chemical Library (DEL) selection against the WDR domain of WDR91, followed by machine learning to generate a model that was then used to predict ligands from the synthetically accessible Enamine REAL database. Screening of predicted compounds enabled us to identify the hit compound 1, which binds selectively to WDR91 with a KD of 6 {+/-} 2 M by surface plasmon resonance. The co-crystal structure confirmed the binding of 1 to the WDR91 side pocket, in proximity to cysteine 487. Machine learning-assisted structure activity relationship-by-catalog validated the chemotype of 1 and led to the discovery of covalent analogs 18 and 19. Intact mass LC-MS and differential scanning fluorimetry confirmed the formation of a covalent adduct, and thermal stabilization, respectively. The discovery of 1, 18, 19, accompanying SAR, and co-crystal structures will provide valuable insights for designing more potent and selective compounds against WDR91, thus accelerating the development of novel chemical tools to evaluate the therapeutic potential of WDR91 in disease.
- Citations
- 22
- FWCI
- 3.42
- Field percentile
- top 6%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A resource to enable chemical biology and drug discovery of WDR Proteins
C. H. Arrowsmith, S. Ackloo, … Arnautova·bioRxiv·Mar 3, 2024
- Identification of unique and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
Dario Akaberi, Monireh Pourghasemi Lati, … Johan Lennerstrand·Antimicrobial Agents and ChemotherapyPeer-reviewed·Aug 28, 2024
- Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Non-structural Proteins Inhibitors
Xudong Wang, Liwei Xiong, … Xiaojie Lu·Journal of the American Chemical SocietyPeer-reviewed·Nov 22, 2024
- Structure-based discovery of inhibitors of Mac1 domain of nonstructural protein-3 of SARS-CoV-2 by machine learning-augmented screening of chemical space
Fuqiang Ban, Rahul Ravichandran, … Francesco Gentile·Scientific ReportsPeer-reviewed·Aug 3, 2026
- Discovery of Drug-like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3
R. S. Virdi, R. V. Bavisotto, … D. Frick·bioRxiv·Jul 6, 2020
- Peptide Mold: A Novel Strategy for Mapping Potential Binding Sites in Protein Targets
Pritam V. Bagwe, Yogesh Jagtap, … Prashant S. Kharkar·bioRxiv·Feb 28, 2024